tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Stock Investors

139 Followers
Based on 730,199 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GANX
On average, investors allocate 0.00% of their portfolios to GANX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GANX

1.8%
Last 7
Days
12.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GANX, out of 730,199 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GANX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$3.73
Increased
<0.01%
$3.09
Opened
0.00%
$2.24
Based on the activity of 13,714 investors who made their portfolios public
The table shows changes in GANX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GANX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
3.88%
-1.04%
-7.27%
567.30M
Consumer Cyclical
AMC Entertainment
5.50%
-1.08%
-6.88%
893.62M
Communication Services
Riot Platforms
5.21%
+3.75%
+2.83%
3.00B
Financial
Marathon Digital Holdings
5.64%
+0.31%
-2.68%
5.49B
Financial
Enterprise Products Partners
5.79%
+0.24%
-2.75%
62.68B
Energy
Li Auto
5.51%
-1.23%
-6.65%
24.93B
Consumer Cyclical
Trade Desk
4.63%
-0.03%
-4.95%
39.64B
Technology
Lucid Group
5.50%
-0.75%
-6.94%
5.80B
Consumer Cyclical
Plug Power
4.91%
-1.17%
-7.06%
1.77B
Industrials
Coherus Biosciences
2.67%
-1.40%
-8.90%
247.43M
Healthcare
Based on the activity of 730,199 active portfolios
Open your Smart Portfolio

GANX Investor Analysis

GANX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
2.8%
of GANX holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GANX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.1%
of GANX holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GANX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
36.1%
of GANX holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GANX stock investors
See who invests in GANX according to age group and performance.

FAQ

How many retail Investors hold GANX?
<0.1% of TipRanks' retail investors hold GANX in their portfolios.
    What is GANX Investor Sentiment?
    GANX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GANX in the last 7 days?
      ▲ 1.8% of TipRanks' retail investors changed their holding of GANX in the last 7 days.
        What percentage of retail investors changed their holding of GANX in the last 30 days?
        ▼ 12.0% of TipRanks' retail investors changed their holding of GANX in the last 30 days.
          What is the average age of retail investors who hold GANX?
          The average age of GANX Holders is between 35–55.
            What other stocks have GANX investors also bought?
            GANX Investors also bought CHPT, AMC, RIOT, MARA, EPD, LI, TTD, LCID, PLUG, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              GERNGeron
              HCAHCA Healthcare
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis